
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
The Long Run with Luke Timmerman
00:00
Biotac
We need to have a different, we needt take the covid sense of urgency, and that should be everyday life. I just think im anything incremental. So i guess we're really focused on things that are trying to make up a large clinical impact. We don't really think about the money when we invest. And it turns out, like, not thinking about the money is the way to make the most money. But you can't think about it. It screws up your decision making. so you have to think about like, ing the most impact and having the best science, and then i'm not thinking about themoney and taking the risk.
Transcript
Play full episode